ADDF Joins BIRAX Regenerative Medicine Initiative

The Alzheimer's Drug Discovery Foundation (ADDF) has joined the BIRAX partnership as part of its third call for proposals. BIRAX (the Britain Israel Research and Academic Exchange Partnership) is a £10 million initiative that brings together British and Israeli scientists to tackle some of the world’s most challenging diseases.

The third BIRAX Research Call was discussed by Prime Minister David Cameron and Prime Minister Netanhyau and will fund joint research to tackle the most urgent global health challenges.

A Downing Street spokesperson said, “The two leaders welcomed the growing economic ties between the UK and Israel, particularly the progress that had been made since the PM’s visit in a number of areas, including research and science, with an additional £3 million of new funding for bilateral medical research projects in 2017."

As well as a general call for proposals, the third call includes a particular focus on Alzheimer’s, arthritis, cardiovascular disease, Type 1 diabetes, MS and Parkinson’s. Successful research projects will be supported by leading medical research foundations including the ADDF, Alzheimer’s Society, Arthritis Research UK, the British Heart Foundation, JDRF, the MS Society and Parkinson’s UK.

For further information, visit the BIRAX 3rd call page.